Oxygen Biotherapeutics Inc (NASDAQ:OXBT)

Yacabe (41.71) Submitted: 10/13/2011 8:34:08 PM : Start Price: $2.40 OXBT Score: -39.68

Oxygen Biotherapeutics is a very fascinating name. At least I think so. That's why I got into researching it. Thing is, though, it's got so many competitors it ain't even funny. All of them seemed at least equally capable, if not more capable. So I think it's safe to say that OXBT is going to go down because it's in a rough world, and it doesn't have the capability to rise to the top. In addition, its sales have gone down this year. Losing demand in its products, and giving them to its capable competitors is not exactly the formula for rising stock price.